Pharmacokinetic Interactions with RifampicinClinical Relevance

被引：0
|
作者：
Mikko Niemi
Janne T. Backman
Martin F. Fromm
Pertti J. Neuvonen
Kari T. Kivistö
机构：
[1] University of Helsinki and Helsinki University Central Hospital,Department of Clinical Pharmacology
[2] Dr Margarete Fischer-Bosch Institut für Klinische Pharmakologie,undefined
[3] Bosch Institut für Klinische Pharmakologie,undefined
来源：
Clinical Pharmacokinetics | 2003年 / 42卷
关键词：
Verapamil; Rifampicin; Zolpidem; Propafenone; Repaglinide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The antituberculosis drug rifampicin (rifampin) induces a number of drug-metabolising enzymes, having the greatest effects on the expression of cytochrome P450 (CYP) 3A4 in the liver and in the small intestine. In addition, rifampicin induces some drug transporter proteins, such as intestinal and hepatic P-glycoprotein. Full induction of drug-metabolising enzymes is reached in about 1 week after starting rifampicin treatment and the induction dissipates in roughly 2 weeks after discontinuing rifampicin.
引用
收藏
页码：819 / 850
页数：31
相关论文
共 50 条
  • [1] Pharmacokinetic interactions with rifampicin -: Clinical relevance
    Niemi, M
    Backman, JT
    Fromm, MF
    Neuvonen, PJ
    Kivistö, KT
    CLINICAL PHARMACOKINETICS, 2003, 42 (09) : 819 - 850
  • [2] OXCARBAZEPINE - PHARMACOKINETIC INTERACTIONS AND THEIR CLINICAL RELEVANCE
    BARUZZI, A
    ALBANI, F
    RIVA, R
    EPILEPSIA, 1994, 35 : S14 - S19
  • [3] Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions
    Hurle, A. Dominguez-Gil
    Sanchez Navarro, A.
    Garcia Sanchez, M. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 97 - 106
  • [4] Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
    Rombola, Laura
    Scuteri, Damiana
    Marilisa, Straface
    Watanabe, Chizuko
    Morrone, Luigi Antonio
    Bagetta, Giacinto
    Corasaniti, Maria Tiziana
    LIFE-BASEL, 2020, 10 (07): : 1 - 30
  • [5] Pharmacokinetic drug interactions by herbal drugs: Critical evaluation and clinical relevance
    Unger, Matthias
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (21-22) : 571 - 577
  • [6] Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
    Bruggemann, Roger J. M.
    Alffenaar, Jan-Willem C.
    Blijlevens, Nicole M. A.
    Billaud, Eliane M.
    Kosterink, Jos G. W.
    Verweij, Paul E.
    Burger, David M.
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (10) : 1441 - 1458
  • [7] CLINICAL RELEVANCE OF PHARMACOKINETIC INTERACTIONS BETWEEN CARDIAC-GLYCOSIDES AND ANTIARRHYTHMIC DRUGS
    HOOYMANS, PM
    MERKUS, FWHM
    PHARMACY INTERNATIONAL, 1986, 7 (10): : 252 - 254
  • [8] Relevance of the drug-drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
    Dekkers, Bart G. J.
    Bierman, Wouter F. W.
    Touw, Daan J.
    Alffenaar, Jan-Willem C.
    AIDS, 2019, 33 (06) : 1100 - 1102
  • [9] RELEVANCE OF PHARMACOKINETIC STUDIES IN VOLUNTEERS
    TOON, S
    CLINICAL PHARMACOKINETICS, 1993, 25 (04) : 259 - 262
  • [10] Pharmacokinetic Drug Interactions between Anticancer Therapeutics and Drugs of Complementary Medicine: Mechanisms and Clinical Relevance
    Unger, Matthias
    FORSCHENDE KOMPLEMENTARMEDIZIN, 2011, 18 (04): : 213 - 218
12345